Bibliotecas PUC-SP - Busca Integrada

A novel event-free survival endpoint in locally advanced pancreatic cancer

Por Pascal Hammel, Ewa Carrier, Mairead Carney, Mark Eisner, Thomas Fleming
Publicado no Therapeutic Advances in Medical Oncology (2021-11-01)

Prolonged Survival in a Patient with Neuroendocrine Tumor of the Cecum and Diffuse Peritoneal Carcinomatosis

Por Louis de Mestier, Cindy Neuzillet, Olivia Hentic, Reza Kianmanesh, Pascal Hammel, Philippe Ruszniewski
Publicado no Case Reports in Gastroenterology (2012-04-01)

Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021

Por Anthony Turpin, Mehdi el Amrani, Jean-Baptiste Bachet, Daniel Pietrasz, Lilian Schwarz, Pascal Hammel
Publicado no Cancers (2020-12-01)

Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake

Por Talia Golan, Raffaella Casolino, Andrew V. Biankin, Pascal Hammel, Kristen D. Whitaker, Michael J. Hall, Douglas L. Riegert-Johnson
Publicado no Therapeutic Advances in Medical Oncology (2023-09-01)

Fatal Bile Duct Necrosis: A Rare Complication of Transcatheter Arterial Chemoembolization in a Patient with Endocrine Hepatic Metastasis

Por Anne-Laure Pelletier, Pascal Hammel, Magali Zappa, Pierre Bedossa, Vinciane Rebours, Olivia Hentic, Frédérique Maire, Philippe Levy, Philippe Ruszniewski
Publicado no Case Reports in Gastroenterology (2008-11-01)

Management of esogastric cancer in older patients

Por Thomas Aparicio, Anna Carteaux-Taieb, Amélie Arégui, Janina Estrada, Geoffroy Beraud-Chaulet, Virginie Fossey-Diaz, Pascal Hammel, Pierre Cattan
Publicado no Therapeutic Advances in Medical Oncology (2024-08-01)

Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic...

Por Pascal Hammel, Rene Adam, Francis Levi, Amal Attari, Mohamed Bouchahda, Ayhan Ulusakarya, Anne Thirot-Bidault, Rachel Bossevot, Richard Tuligenga
Publicado no BMJ Open (2023-06-01)

Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies

Por Anthony Turpin, Cindy Neuzillet, Elise Colle, Nelson Dusetti, Rémy Nicolle, Jérôme Cros, Louis de Mestier, Jean-Baptiste Bachet, Pascal Hammel
Publicado no Therapeutic Advances in Medical Oncology (2022-09-01)

Time interval from last visit to imaging diagnosis influences outcome in pancreatic adenocarcinoma: A regional population-based study on linked medico-administrative and clinical d...

Por Vittoria Balzano, Emeline Laurent, Aline-Marie Florence, Anne-Isabelle Lecuyer, Carole Lefebvre, Patrick Heitzmann, Pascal Hammel, Thierry Lecomte, Leslie Grammatico-Guillon
Publicado no Therapeutic Advances in Medical Oncology (2022-09-01)

Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors

Por Pascal Hammel, Carole Vitellius, Émeric Boisteau, Mathilde Wisniewski, Elise Colle, Marc Hilmi, Christelle Dengremont, Sandra Granier, Anthony Turpin, Louis de Mestier, Cindy Neuzillet
Publicado no Therapeutic Advances in Medical Oncology (2020-07-01)

Muscle Loss During First‐Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity

Por Pauline Parent, Frédéric Pigneur, Marc Hilmi, Aurélien Carnot, Marie‐Line Garcia Larnicol, Dewi Vernerey, Alain Luciani, Pascal Hammel, Julie Henriques, Cindy Neuzillet, Anthony Turpin
Publicado no Journal of Cachexia, Sarcopenia and Muscle (2025-02-01)

Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mutational profile for the differential diagnosis with primary m...

Por Alice de Malet, Magali Svrcek, Anne Kerbaol, Nathalie Theou-Anton, Sandra Granier, Safi Dokmak, François Paye, Thierry André, Louis de Mestier, Jérôme Cros, Pascal Hammel
Publicado no Therapeutic Advances in Medical Oncology (2021-10-01)

Potential barriers to performing adapted physical activity in patients with digestive cancer: results of the prospective observational APACADIG study

Por Clémence Trihan, Cindy Richard, Emeric Boisteau, Thomas Grainville, Géraldine Perkins, Claire Gouriou, Eugénie Rigault, Anne-Sophie Guerard, Etienne Le Brelot, Amélie Rebillard, Pascal Hammel, Astrid Lièvre
Publicado no Therapeutic Advances in Medical Oncology (2025-10-01)

Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens

Por Thomas Chaigneau, Lina Aguilera Munoz, Caroline Oger, Clémence Gourdeau, Olivia Hentic, Lucie Laurent, Nelly Muller, Marco Dioguardi Burgio, Marie-Pauline Gagaille, Philippe Lévy, Vinciane Rebours, Pascal Hammel, Louis de Mestier
Publicado no Therapeutic Advances in Medical Oncology (2023-03-01)

Identification of a large intra-exonic deletion in exon 18 in a pancreatic ductal adenocarcinoma

Por Inès Debbabi, Sophie Vacher, Cindy Neuzillet, Jérome Cros, Françoise Revillon, Ambre Petitalot, Anthony Turpin, Samantha Antonio, Elodie Girard, Célia Dupain, Maud Kamal, Pascal Hammel, Ivan Bièche, Julien Masliah-Planchon, Sandrine M. Caputo
Publicado no Therapeutic Advances in Medical Oncology (2023-01-01)

Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study

Por Alix Riescher-Tuczkiewicz, Jules Grégory, Frederic Bert, Magaly Zappa, Anna Pellat, Valerie Lalande, Claire Gallois, Jean-Luc Mainardi, Jean-Baptiste Bachet, Jérôme Robert, Anne Sophie Bourrel, Romain Coriat, Dominique Thabut, Pascal Hammel, Vinciane Rebours, Diane Lorenzo
Publicado no Therapeutic Advances in Medical Oncology (2024-06-01)

SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors

Por Pascal Hammel, Denis Smith, Pauline Afchain, Sophie Dominguez-Tinajero, Jean-François Seitz, Astrid Lievre, Eric Van Cutsem, Eric Assenat, Frédéric Di Fiore, Marc Peeters, Iradj Sobhani, Eric Raymond, Emilie Charton, Dewi Vernerey, Louis De Mestier, Catherine Lombard-Bohas
Publicado no Therapeutic Advances in Medical Oncology (2024-11-01)

Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluoroura...

Por Emilie Charton, Jean‐Baptiste Bachet, Pascal Hammel, Jérôme Desramé, Benoist Chibaudel, Romain Cohen, Philippe Debourdeau, Jérome Dauba, Thierry Lecomte, Jean‐François Seitz, Christophe Tournigand, Thomas Aparicio, Véronique Guerin‐Meyer, Julien Taieb, Julien Volet, Christophe Louvet, Amélie Anota, Franck Bonnetain
Publicado no Cancer Medicine (2019-09-01)

Targeting DNA Damage Repair Mechanisms in Pancreas Cancer

Por Lukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, Tamara Matysiak-Budnik, Jean-Luc Van Laethem, Teresa Macarulla, Estelle Cauchin, Alexander Kleger, Alica K. Beutel, Johann Gout, Albrecht Stenzinger, Eric Van Cutsem, Joaquim Bellmunt, Pascal Hammel, Eileen M. O’Reilly, Thomas Seufferlein
Publicado no Cancers (2021-08-01)

Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features

Por Jérôme Raffenne, Fernando A. Martin, Rémy Nicolle, Marina Konta, Yuna Blum, Jérôme Torrisani, Francesco Puleo, Jean Baptiste Bachet, Magali Svrcek, Armel Bardier-Dupas, Jean Francois Emile, Peter Demetter, Miroslav Radman, Jean Luc Van Laethem, Pascal Hammel, Vinciane Rebours, Valérie Paradis, Anne Couvelard, Jérôme Cros
Publicado no Cancers (2021-03-01)